Log in

Relevant bibliographies by topics / DVT Prophylaxis / Journal articles

To see the other types of publications on this topic, follow the link: DVT Prophylaxis.

Journal articles on the topic 'DVT Prophylaxis'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'DVT Prophylaxis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Deng, Jing, Lisa Thomas, Huijing Li, et al. "Overuse of DVT Prophylaxis in Medical Inpatients." Blood 126, no. 23 (2015): 5563. http://dx.doi.org/10.1182/blood.v126.23.5563.5563.

Full text

Abstract:

Abstract Introduction: Unfractionated heparin (UFH), or low-molecular-weight heparin (LMWH), is commonly used with mechanical prophylaxis as an anticoagulant to reduce the risk for venous thromboembolism (VTE). However, overuse of these prophylaxes can increase the risk of bleeding, heparin-induced thrombocytopenia (HIT) and associated medical cost. PURPOSE: The aim of this study is to determine the incidence of DVT prophylaxis among hospitalized nonsurgical patients in a community medical center. To evaluate the use of the prophylaxes as described above, the investigators collected data on me

APA, Harvard, Vancouver, ISO, and other styles

2

SHEIKH, MUHAMMAD SAJID, and MUHAMMAD FASIH UR REHMAN. "DVT PROPHYLAXIS." Professional Medical Journal 18, no. 02 (2011): 275–79. http://dx.doi.org/10.29309/tpmj/2011.18.02.2080.

Full text

Abstract:

Objectives: To evaluate the effectiveness of LMWH prophylaxis for DVT in high risk patients after general surgery. Study design: Randomized controlled study. Setting: Surgical Unit-IV, District Head Quarters Hospital, Faisalabad. Period: From March 2009 to August 2009. Patients and Methods: Sixty patients in the LMWH group were given perioperative enoxaparin (Clexane) as prophylaxis while compression stockings were used in another control group comprised of 60 patients. At 5th postoperative day, Doppler study was performed to detect DVT in both groups. Categorical data were analyzed for signif

APA, Harvard, Vancouver, ISO, and other styles

3

Sarker, A., D. Yelle, K. Wooller, and E. M. Kelly. "A153 INCIDENCE OF DEEP VEIN THROMBOSIS (DVT) & PROPHYLAXIS PRACTICES IN DECOMPENSATED CIRRHOSIS INPATIENTS." Journal of the Canadian Association of Gastroenterology 3, Supplement_1 (2020): 17–18. http://dx.doi.org/10.1093/jcag/gwz047.152.

Full text

Abstract:

Abstract Background The coagulation cascade is disturbed in cirrhosis. Patients are at risk for bleeding and coagulation through an imbalance of pro and anticoagulant factors. Aims We evaluated the incidence of DVTs and prevalence of DVT prophylaxis in hospitalized patients with decompensated cirrhosis. Methods A retrospective study of decompensated cirrhotic patients admitted to a tertiary care hospital. We evaluated the incidence of DVTs and use of DVT prophylaxis in this cohort. We also evaluated differences in patient characteristics in those who received DVT prophylaxis and between patien

APA, Harvard, Vancouver, ISO, and other styles

4

Ah-See, K. W., J. Kerr, and D. W. Sim. "Prophylaxis for venous thromboembolism in head and neck surgery: the practice of otolaryngologists." Journal of Laryngology & Otology 111, no. 9 (1997): 845–49. http://dx.doi.org/10.1017/s0022215100138770.

Full text

Abstract:

AbstractDeep venous thrombosis (DVT) and pulmonary embolism (PE) are an important cause of morbidity and mortality in the surgical patient. The first guideline produced by the Scottish Intercollegiate Guidelines Network was for the prophylaxis of venous thromboembolism. Patients undergoing major head and neck cancer surgery commonly exhibit risk factors for venous thromboembolism. Currently, however, there are no data on its incidence in these patients. A questionnaire survey was performed to assess the current practice of consultant otolaryngologists regarding DVT prophylaxis in patients unde

APA, Harvard, Vancouver, ISO, and other styles

5

Lin, Feng-Fei, Chao-Hui Lin, Bin Chen, and Ke Zheng. "Combination Prophylaxis versus Pharmacologic Prophylaxis Alone for Preventing Deep Vein Thrombosis in Hip Surgery." HIP International 26, no. 6 (2016): 561–66. http://dx.doi.org/10.5301/hipint.5000384.

Full text

Abstract:

Purpose To evaluate the comparative efficacy and safety of combination pharmacologic and graduated compression stockings (GCS) prophylaxis versus pharmacological prophylaxis alone for preventing deep vein thrombosis (DVT) and pulmonary embolism (PE) in hip surgery. Methods Relevant publications indexed in PubMed, Cochrane Library, Embase, Web of Science, Wanfang Data, CNKI and Sinomed (CBM) were identified. Appropriate articles identified from the reference lists of the above searches were also reviewed. Results Significant differences in the rate of distal DVT were observed between combinatio

APA, Harvard, Vancouver, ISO, and other styles

6

Cheng, Gregory, Crystal Chan, Ying Ting Liu, et al. "Incidence of Deep Vein Thrombosis in Hospitalized Chinese Medical Patients and the Impact of DVT Prophylaxis." Thrombosis 2011 (February 15, 2011): 1–4. http://dx.doi.org/10.1155/2011/629383.

Full text

Abstract:

Objective. To evaluate the incidence of deep vein thrombosis in hospitalized Chinese medical patients and the impact of DVT prophylaxis. Methods. All cases of confirmed proximal DVT from 1 January 2005 to 31 December 2008 were reviewed retrospectively to determine the presence of risk factors and whether DVT developed: during hospitalization in medical wards or in case of readmission with a diagnosis of DVT within 14 days of discharge from a recent admission to medical wards. The impact of prophylaxis will be estimated by comparing the annual incidence of proximal DVT among medical patients ho

APA, Harvard, Vancouver, ISO, and other styles

7

Shirol, S. S., Srinivas Kodaganur, M. Raghavendra Rao, and Vinaykumar Tiwari. "The conundrum of deep vein thrombosis prophylaxis in burns in India and review of literature." Indian Journal of Plastic Surgery 50, no. 03 (2017): 288–94. http://dx.doi.org/10.4103/ijps.ijps_179_15.

Full text

Abstract:

ABSTRACTObjective: The aim is to assess the practice of deep vein thrombosis (DVT) prophylaxis among the plastic surgeons attending National Academy of Burns India Conference 2012 (NABICON 2012). Background: DVT prophylaxis in burns is a controversial issue as there is no consensus among the community of burn surgeons about the prevalence of DVT, the incidence of pulmonary embolism, the indications for DVT prophylaxis, dosage and duration of low molecular weight heparins (LMWH) and the complications related to DVT and LMWH. Methodology: A survey was conducted among plastic surgeons attending t

APA, Harvard, Vancouver, ISO, and other styles

8

Wido, Akbar, Abdul Hafid Bajamal, Tedy Apriawan, Muhammad Arifin Parenrengi, and Asra Al Fauzi. "Deep vein thrombosis prophylaxis use in traumatic brain injury patients in tropical climate." International journal of health & medical sciences 5, no. 1 (2022): 67–74. http://dx.doi.org/10.21744/ijhms.v5n1.1840.

Full text

Abstract:

Deep Vein Trombosis (DVT) is one of the extracranial complications after TBI. Prophylaxis DVT using on TBI reduce incidence and mortality. Climate variants of an area affect the risk of DVT. UV ray increasing synthesis of vitamin D and lowering risk of thrombus fomation. A systematic review and meta-analysis we performed according PRISMA guidelines. A through literature search was conducted on PubMed, Scopus, and Cochrane database. Total 3 publications match study criteria with 178 samples, without 144 samples and 34 samples with prophylaxis. The overall incidence is 5% (0-6.8%), without 6.25%

APA, Harvard, Vancouver, ISO, and other styles

9

Kukar, Moshim, Joseph Asaro, Anthony Aquino, Adrienne Groman, Joseph Skitzki, and John M. Kane. "Incidence of Venous Thromboembolic Events in Mandated Risk Assessment versus Optional DVT Prophylaxis Era at a Large Tertiary Cancer Center." American Surgeon 81, no. 9 (2015): 893–98. http://dx.doi.org/10.1177/000313481508100924.

Full text

Abstract:

Cancer patients are thought to be at high risk for venous thromboembolic events (DVT/PE). Beginning in October 2007, our tertiary cancer center instituted “mandated risk assessment” computerized DVT prophylaxis order entry, for all hospital admissions with an option for active opt out by the physician with a stated reason. Retrospective review of all DVT/PE events within 30 days of a hospital admission [any inpatient admission (IA) and outpatient surgery (OPS)] in comparable “optional (O)” (January 2005—September 2007) vs “mandated risk assessment (M)” (October 2007–May 2010) DVT prophylaxis o

APA, Harvard, Vancouver, ISO, and other styles

10

Busato, Cesar Roberto, Ricardo Zanetti Gomes, Dieyson Martins de Melo Costa, and Tiago Francisco Meleiro Zubiolo. "Evaluation of thromboprophylaxis in medium-sized general hospital." Jornal Vascular Brasileiro 13, no. 1 (2014): 05–11. http://dx.doi.org/10.1590/jvb.2014.003.

Full text

Abstract:

CONTEXT: Deep vein thrombosis (DVT) is a serious, common disease whose complications include pulmonary thromboembolism (PTE) and postthrombotic syndrome. The importance and benefits of correct and effective pharmacological prophylaxis for DVT are well documented. OBJECTIVES: The aims of this study were to evaluate adequacy of prophylaxis for DVT and PTE at the Santa Casa de Misericórdia de Ponta Grossa (SCMPG), Paraná, Brazil, and determine risk stratification for patients hospitalized in this institution. METHODS: A cohort study was conducted to assess DVT prophylaxis of patients hospitalized

APA, Harvard, Vancouver, ISO, and other styles

11

Kresowik, Timothy F., David S. Nilasena, Anton F. Piskac, et al. "Deep Vein Thrombosis Prophylaxis in Medicare Patients with Ischemic Stroke: Results from the National Stroke Project." Stroke 32, suppl_1 (2001): 337. http://dx.doi.org/10.1161/str.32.suppl_1.337.

Full text

Abstract:

116 Background: Patients with ischemic stroke (IS) often have impaired mobility that can increase their risk of deep vein thrombosis (DVT). Current guidelines recommend prophylactic treatment for DVT in immobile IS patients. As part of HCFA’s National Stroke Project, we examined national patterns of DVT prophylaxis for Medicare patients hospitalized with IS. Methods: Project data were abstracted from a national sample of Medicare inpatient charts (discharge dates 4/98 - 3/99). All U.S. states, the District of Columbia and Puerto Rico were sampled using a systematic random approach. All medical

APA, Harvard, Vancouver, ISO, and other styles

12

Kucher, Nils, Victor Tapson, Rene Quiroz, et al. "Gender differences in the administration of prophylaxis to prevent deep venous thrombosis." Thrombosis and Haemostasis 93, no. 02 (2005): 284–88. http://dx.doi.org/10.1160/th04-08-0513.

Full text

Abstract:

SummaryWe investigated gender differences in the prescription of prophylaxis against deep vein thrombosis (DVT) in 2,619 patients who developed acute DVT while being hospitalized for reasons other than DVT or were diagnosed with acute DVT as outpatients but who had been hospitalized within 30 days prior to DVT diagnosis. Men were 21% more likely than women to receive prophylaxis (OR 1.21, 95% CI 1.03–1.43; p = 0.021) after adjusting for DVT risk factors, including surgery, trauma, prior DVT, age, and cancer.

APA, Harvard, Vancouver, ISO, and other styles

13

Gibson, Charlisa D., Mai O. Colvin, Michael J. Park, et al. "Prevalence and Predictors of Deep Vein Thrombosis in Critically Ill Medical Patients Who Underwent Diagnostic Duplex Ultrasonography." Journal of Intensive Care Medicine 35, no. 10 (2018): 1062–66. http://dx.doi.org/10.1177/0885066618813300.

Full text

Abstract:

Introduction: Deep vein thrombosis (DVT) is a recognized but preventable cause of morbidity and mortality in the medical intensive care unit (MICU). We examined the prevalence and risk factors for DVT in MICU patients who underwent diagnostic venous duplex ultrasonography (DUS) and the potential effect on clinical outcomes. Methods: This is a retrospective study examining prevalence of DVT in 678 consecutive patients admitted to a tertiary care level academic MICU from July 2014 to 2015. Patients who underwent diagnostic DUS were included. Potential conditions of interest were mechanical venti

APA, Harvard, Vancouver, ISO, and other styles

14

Turpie, Alexander G. G. "A Prospective Registry on Venous Thromboembolic Events: Findings from PROVE." Blood 104, no. 11 (2004): 1769. http://dx.doi.org/10.1182/blood.v104.11.1769.1769.

Full text

Abstract:

Abstract Introduction Venous thromboembolism (VTE) is a major health problem, especially in the elderly. A variety of intrinsic factors, acute medical illnesses and surgery have been shown to increase VTE risk. Despite this, VTE has not been adequately described in terms of clinical history, clinical risk factors and VTE prophylaxis. The objective of the Prospective Registry On Venous thromboembolic Events (PROVE) is to characterize the profile of patients with ultrasound-confirmed deep-vein thrombosis (DVT), the prior use and type of VTE prophylaxis and its relationship to demographic and com

APA, Harvard, Vancouver, ISO, and other styles

15

Khaldi, Ahmad, Naseem Helo, Michael J. Schneck, and Thomas C. Origitano. "Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population." Journal of Neurosurgery 114, no. 1 (2011): 40–46. http://dx.doi.org/10.3171/2010.8.jns10332.

Full text

Abstract:

Object Venous thromboembolism (VTE), a combination of deep venous thrombosis (DVT) and pulmonary embolism (PE), is a major cause of morbidity and death in neurosurgical patients. This study evaluates 1) the risk of developing lower-extremity DVT following a neurosurgical procedure; 2) the timing of initiation of pharmacological DVT prophylaxis upon the occurrence of VTE; and 3) the relationship between DVT and PE as related to VTE prophylaxis in neurosurgical patients. Methods The records of all neurosurgical patients between January 2006 and December 2008 (2638 total) were reviewed for clinic

APA, Harvard, Vancouver, ISO, and other styles

16

Ananthalakshmi, G., Chetan Sai Potu, Tharun Kandhuri, B. Lakshmi Priya, Pooja Reddy Sollipuram, and Salome Satya Vani. "A prospective study on risk assessment and DVT prophylaxis in intensive care unit and patients in wards at tertiary care hospital." International Journal of Research in Pharmaceutical Sciences 16, no. 1 (2025): 81–90. https://doi.org/10.26452/ijrps.v16i1.4741.

Full text

Abstract:

Deep Vein Thrombosis (DVT) is a significant vascular condition, ranking third in morbidity and mortality, primarily affecting hospitalized patients, particularly those undergoing surgery or with underlying medical conditions. This prospective observational study aimed to evaluate the efficacy of DVT risk assessment and prophylaxis in reducing its incidence among hospitalized patients, while examining pharmacological agents and prophylaxis duration across various medical conditions. Conducted on 351 patients in a tertiary care hospital between December 2021 and September 2022, the study recorde

APA, Harvard, Vancouver, ISO, and other styles

17

Makhdom, Asim M., Simon Garceau, and Ronald Dimentberg. "Fatal Pulmonary Embolism following Achilles Tendon Repair: A Case Report and a Review of the Literature." Case Reports in Orthopedics 2013 (2013): 1–3. http://dx.doi.org/10.1155/2013/401968.

Full text

Abstract:

Deep venous thrombosis (DVT) is a significant source of morbidity in orthopaedic surgery. It can progress to a pulmonary embolism, a significant source of mortality. Up to date, patients with Achilles tendon rupture routinely do not receive DVT chemical prophylaxis. We are presenting a case of fatal pulmonary embolism after a surgically treated Achilles tendon rupture in a forty-two-year-old male healthy patient. In the current body of the literature, the reported incidence of DVT after Achilles tendon rupture is highly variable ranging from less than 1% to 34%, and there is a disagreement in

APA, Harvard, Vancouver, ISO, and other styles

18

Engler, Ian D., Jack T. Bragg, and Suzanne L. Miller. "Incidence of Deep Venous Thrombosis Associated With Proximal Hamstring Rupture." Orthopaedic Journal of Sports Medicine 7, no. 12 (2019): 232596711988848. http://dx.doi.org/10.1177/2325967119888486.

Full text

Abstract:

Background: Rates of deep venous thrombosis (DVT) have been studied for most common orthopaedic injuries. However, rates and risk factors have not been published for proximal hamstring injuries. Purpose: To determine the incidence of symptomatic DVT associated with proximal hamstring rupture and associations with prophylactic anticoagulation. Study Design: Case series; Level of evidence, 4. Methods: Inclusion criteria included all complete and, in a separate cohort, partial proximal hamstring ruptures treated by the senior author from 2007 through 2018 with at least 8 weeks of follow-up. Tendi

APA, Harvard, Vancouver, ISO, and other styles

19

Kampamba, Martin, Davison Kafulu, Christabel Nang’andu Hikaambo, Steward Mudenda, Audrey Hamachila, and Jimmy M. Hangoma. "Evaluation of pharmacological prophylaxis for deep venous thrombosis in hospitalized patients with risk factors at the university teaching hospitals, Lusaka, Zambia." International Journal of Basic & Clinical Pharmacology 12, no. 1 (2022): 10. http://dx.doi.org/10.18203/2319-2003.ijbcp20223349.

Full text

Abstract:

Background: Deep venous thrombosis is a common clinical problem accounting for high rates of morbidity and mortality. The existence of risk factors, which include trauma, venous stasis, and hypercoagulability, is linked to the occurrence of the condition. Objective of current study was to evaluate DVT risk factors and prophylaxis pattern of use for patients who were admitted at the University Teaching Hospitals in Lusaka, Zambia.Methods: A cross-sectional study was conducted using medical files for patients who were hospitalized at the University Teaching Hospitals in Lusaka, Zambia from May 2

APA, Harvard, Vancouver, ISO, and other styles

20

Amin, Alpesh N., Jay Lin, Stephen Thompson, and Daniel Wiederkehr. "Real-World Rates of In-hospital and Postdischarge Deep-Vein Thrombosis and Pulmonary Embolism in At-Risk Medical Patients in the United States." Clinical and Applied Thrombosis/Hemostasis 17, no. 6 (2011): 611–19. http://dx.doi.org/10.1177/1076029611405035.

Full text

Abstract:

Hospitalized medical patients are at risk of deep-vein thrombosis (DVT) and pulmonary embolism (PE). We evaluated inpatient and postdischarge DVT/PE and thromboprophylaxis rates in US medical patients, using patient admissions from January 2005 to November 2007 in the Premier Perspective™-i3 Pharma Informatics database. Among 15 721 patients with cancer, congestive heart failure, severe lung disease, and infectious disease, 39.0% received inpatient thromboprophylaxis, with the highest rate in patients with cancer (51.9%). In all, 3.4% received outpatient pharmacological prophylaxis. Mean ± SD

APA, Harvard, Vancouver, ISO, and other styles

21

Ahmed, Bakhsh. "Deep Vein Thrombosis (DVT) Prophylaxis in Head-Injured Patients: Current Concepts and Guidelines." Brain Disorders & Therapy 12, no. 4 (2023): 6. https://doi.org/10.35248/2168-975X.23.12.218.

Full text

Abstract:

Background: Abundant evidence from multiple randomized clinical trials conclusively showed that use of thromboprophylaxis in trauma patients is a safe, and effective for decreasing Venous Thromboembolism (VTE). However, despite these evidence-based guidelines, thromboprophylaxis remains either underutilized or suboptimal. With this background, we analysed our own clinical practice regarding initiation of Deep vein thrombosis (DVT) prophylaxis in head-injured patients with or without polytrauma and to know how far our clinical practice is comparable with the existing guidelines. Methods: All he

APA, Harvard, Vancouver, ISO, and other styles

22

Mohammed Alanazi, Aljouharah, Abdullah Assad Ali Raes, Fahd Ali Ali Mahnashi, Muhammad Farooq Abdul Sattar, and Muhammad Suliman Al Anazi. "KNOWLEDGE, PRACTICE, AND ATTITUDE TOWARDS DEEP VEIN THROMBOSIS PROPHYLAXIS AMONG RESIDENTS AND INTERNS IN KING SAUD MEDICAL CITY." International Journal of Advanced Research 11, no. 03 (2023): 131–38. http://dx.doi.org/10.21474/ijar01/16400.

Full text

Abstract:

This study aimed to assess the knowledge, attitude, and practice regarding DVT prophylaxis among residents and interns in King Saud Medical City in Saudi Arabia. A cross-sectional study was conducted using an online questionnaire distributed to 108 participants. The results showed that while the overall knowledge score was 71Â±19, the attitude score was 91Â±12, and the practice score was 65Â±31. There were no significant differences in the scores based on the participants age, gender, nationality, level of qualification, clinical specialty, or years of clinical experience. However, there were

APA, Harvard, Vancouver, ISO, and other styles

23

Efidi, R., J. Rimande, A. Agunloye, A. Ogunseyinde, R. Akinola, and G. Ogbole. "Sonographic Evaluation of Deep Vein Thrombosis in Hospitalized Neurosurgical Trauma Patients in Ibadan, Nigeria." Nigerian Journal of Clinical Practice 26, no. 12 (2023): 1833–38. http://dx.doi.org/10.4103/njcp.njcp_337_23.

Full text

Abstract:

Background: Deep vein thrombosis (DVT) is a major cause of morbidity and mortality in hospitalized trauma patients. Ultrasonography (US) has replaced venography as the initial diagnostic tool for DVT. Aims: The study aimed to determine the incidence of lower limb DVT in hospitalized neurosurgical trauma patients in hospitalized neurosurgical patients. It also aimed to determine the effect of combined thrombo-prophylaxis on the incidence of lower limb deep DVT relative to a single regimen. Patients and Methods: This was a prospective study of 154 adult neurotrauma patients who consecutively had

APA, Harvard, Vancouver, ISO, and other styles

24

Amin, Alpesh N., Jay Lin, Stephen Thompson, and Daniel Wiederkehr. "Real-World Analysis of Venous Thromboembolism Rates and Thromboprophylaxis Prescribing In US Patients with Cancer." Blood 116, no. 21 (2010): 3802. http://dx.doi.org/10.1182/blood.v116.21.3802.3802.

Full text

Abstract:

Abstract Abstract 3802 Background: Deep-vein thrombosis (DVT) is a frequent complication of cancer and treatment of cancer. Among clinical guidelines, there is broad consensus regarding the importance of thromboprophylaxis in hospitalized cancer patients, including prolonged prophylaxis in high-risk patients. The objective of this analysis was to assess the real-world use of prophylaxis for DVT, as well as symptomatic rates of DVT and pulmonary embolism (PE) in cancer patients, both during hospitalization and after hospital discharge. Methods: Data were extracted from the US Premier Perspectiv

APA, Harvard, Vancouver, ISO, and other styles

25

Mathew, Jerrin C., Unnikrishnan Pillai, and Alexander Lacasse. "Extensive Deep Venous Thrombosis in a Patient with Neurolept Malignant Syndrome despite Being on Prophylaxis." Case Reports in Psychiatry 2011 (2011): 1–2. http://dx.doi.org/10.1155/2011/258172.

Full text

Abstract:

The risk of venous thromboembolism (VTE) in patients with Neuroleptic malignant syndrome (NMS) and those on antipsychotic medications is well established. We present here a case whereby the patient had NMS and developed extensive deep venous thrombosis (DVT) despite being on standard DVT Prophylaxis. Our case illustrates that empiric intravenous heparin for the initial few days after the onset of NMS may be considered in those with high risk of VTE, as in such patients standard DVT prophylaxis may not be sufficient. To standardize as to which patients with NMS would be at the highest risk of V

APA, Harvard, Vancouver, ISO, and other styles

26

&NA;. "Indobufen prophylaxis - prevents DVT recurrence." Inpharma Weekly &NA;, no. 886 (1993): 17. http://dx.doi.org/10.2165/00128413-199308860-00046.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

MECHCATIE, ELIZABETH. "Rivaroxaban Approved for DVT Prophylaxis." Hospitalist News 4, no. 8 (2011): 15. http://dx.doi.org/10.1016/s1875-9122(11)70167-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Holley, Aaron B., Lisa K. Moores, and Jeffrey L. Jackson. "Provider preferences for DVT prophylaxis." Thrombosis Research 117, no. 5 (2006): 563–68. http://dx.doi.org/10.1016/j.thromres.2005.04.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Zoler, Mitchel L., and Doug Brunk. "DVT Prophylaxis Following Orthopedic Surgery." Internal Medicine News 38, no. 3 (2005): 55. http://dx.doi.org/10.1016/s1097-8690(05)71499-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Zoler, Mitchel L., and Doug Brunk. "DVT Prophylaxis Following Orthopedic Surgery." Family Practice News 35, no. 3 (2005): 64. http://dx.doi.org/10.1016/s0300-7073(05)71351-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Checketts, MR, and JAW Wildsmith. "Regional block and DVT prophylaxis." Continuing Education in Anaesthesia Critical Care & Pain 4, no. 2 (2004): 48–51. http://dx.doi.org/10.1093/bjaceaccp/mkh005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Bircher, Andrew, and Alexander Chowdhury. "Current DVT prophylaxis: a review." Orthopaedics and Trauma 34, no. 3 (2020): 161–67. http://dx.doi.org/10.1016/j.mporth.2020.03.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

MECHCATIE, ELIZABETH. "Rivaroxaban Approved for DVT Prophylaxis." Rheumatology News 10, no. 8 (2011): 8. https://doi.org/10.1016/s1541-9800(11)70498-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Brunk, Doug, and Mitchel L. Zoler. "DVT Prophylaxis Following Orthopedic Surgery." Rheumatology News 4, no. 3 (2005): 31. https://doi.org/10.1016/s1541-9800(05)70326-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Arnold, Agnes. "DVT Prophylaxis in the Perioperative Setting." British Journal of Perioperative Nursing (United Kingdom) 12, no. 8 (2002): 294–97. http://dx.doi.org/10.1177/175045890201200802.

Full text

Abstract:

This is the first of a two-part article in which Agnes Arnold examines the role of the perioperative nurse in the prophylaxis of lower limb deep vein thrombosis (DVT). This part discusses the pathophysiology of DVT and the methods of assessing an individual's risk of developing the disorder. Part 2, which will appear in the September edition of BJPN, will deal with prophylaxis of DVT. It will critically analyse the research, cost-effectiveness, side-effects and target patient population of each prophylactic regimen.

APA, Harvard, Vancouver, ISO, and other styles

36

Amin, Alpesh N., Jay Lin, and Daniel Wiederkehr. "Prevention of Deep Vein Thrombosis In Patients In the United States with Infectious Diseases." Blood 116, no. 21 (2010): 4389. http://dx.doi.org/10.1182/blood.v116.21.4389.4389.

Full text

Abstract:

Abstract Abstract 4389 Background: Hospitalized patients with infectious diseases are at risk of venous thromboembolism (VTE), encompassing both deep-vein thrombosis (DVT) and pulmonary embolism (PE). Our analysis evaluated real-world thromboprophylaxis use and DVT/PE rates in patients with infectious diseases in hospital, and for 30 days post-discharge. Methods: Data were extracted from the US Premier Perspective(tm)-i3 Pharma Informatics linked database for patients with infectious disease (International Classification of Diseases Ninth Revision codes for infectious and parasitic diseases, s

APA, Harvard, Vancouver, ISO, and other styles

37

Lerner, Robert G., and Tushar M. Shah. "Prevalence of Contraindications to Entering a DVT Prophylaxis Trial in Medical Admissions." Blood 106, no. 11 (2005): 2247. http://dx.doi.org/10.1182/blood.v106.11.2247.2247.

Full text

Abstract:

Abstract Studies have revealed that many patients developing deep vein thrombosis (DVT) during a hospitalization have not received any prior DVT prophylaxis despite a lack of medical contraindications. Many measures have been proposed to increase the use of DVT prophylaxis, including computer assisted reminders, standing admission orders, educational activities, etc. Another measure to increase the use of DVT prophylaxis has been to study special patient populations and extended duration of DVT prophylaxis. We present the prevalence of contraindications to the use of a low-molecular-weight-hep

APA, Harvard, Vancouver, ISO, and other styles

38

John, Sheetal, Atiya R. Faruqui, and Soumya Umesh. "Pharmaco-prophylaxis of deep vein thrombosis for in-patients at risk, in a tertiary care hospital." International Journal of Basic & Clinical Pharmacology 7, no. 1 (2017): 44. http://dx.doi.org/10.18203/2319-2003.ijbcp20175672.

Full text

Abstract:

Background: There is limited data from India on Deep Vein Thrombosis (DVT) Prophylaxis. This study was done in hospitalised patients at high risk for DVT, to determine the patterns and rates of pharmacoprophylaxis, drugs used and their clinical outcomes.Methods: This prospective study screened patients for risk of DVT using the Padua risk assessment model. Padua score ≥4 were included and data on disease demographics, prophylaxis and outcomes of DVT at 12 weeks were collected. Factors affecting prophylaxis were assessed using multivariate logistic regression.Results: Out of 453 screened, 200 e

APA, Harvard, Vancouver, ISO, and other styles

39

Proctor, Mary C., and Lazar J. Greenfield. "Thromboprophylaxis in an Academic Medical Center." Cardiovascular Surgery 9, no. 5 (2001): 426–30. http://dx.doi.org/10.1177/096721090100900502.

Full text

Abstract:

Introduction: Questions regarding which patients require prophylaxis for thromboembolism, what methods should be used and the appropriate duration of treatment remain unanswered. Methods and Materials: A retrospective review from a single academic medical center was undertaken to evaluate prophylactic strategies. Multiple sources of data were used to identify patients who were prophylaxed and those who developed deep vein thrombosis or pulmonary embolism. These data were analyzed to determine factors associated with successful prophylaxis including age, type of prophylaxis and admitting servic

APA, Harvard, Vancouver, ISO, and other styles

40

Nunn, K. P., M. R. Bridgett, M. R. Walters, and I. Walker. "All I want for coagulation." Scottish Medical Journal 56, no. 4 (2011): 183–87. http://dx.doi.org/10.1258/smj.2011.011154.

Full text

Abstract:

Evidence-based medicine underpins modern practice of medicine. This paper describes a fictional consultation between Santa Claus and a doctor regarding deep vein thrombosis (DVT) prophylaxis, giving a review of the evidence for DVT prophylaxis in travellers while exposing the difficulty in applying evidence to atypical clinical encounters. Medline and the Cochrane Library were searched, and guidelines reviewed. Keywords used were DVT, thromboembolism, deep vein thrombosis and air travel-related venous thromboembolism. All relevant studies found, have been included in this review, with addition

APA, Harvard, Vancouver, ISO, and other styles

41

Pancholi, Samir, and Angelo Cuzalina. "Venous Thromboembolism in Abdominoplasty Patients: A Study of Incidence and Prophylaxis Recommendations." American Journal of Cosmetic Surgery 24, no. 2 (2007): 66–79. http://dx.doi.org/10.1177/074880680702400203.

Full text

Abstract:

Introduction: Pulmonary embolism (PE) and deep vein thrombosis (DVT) comprise venous thromboembolism (VTE). VTE is the most common preventable cause of death in postsurgical hospitalized patients. The literature consistently defines prophylaxis as being integral to avoiding VTE. No study, however, specifically addresses this with abdominoplasty, a high-VTE-risk cosmetic procedure. This study aims to fill this void by providing specific data on VTE incidence and, through comprehensive literature review, providing specific abdominoplasty prophylaxis recommendations. Methods: A retrospective revi

APA, Harvard, Vancouver, ISO, and other styles

42

Major, Kevin M., Matthew Wilson, Gregg K. Nishi, et al. "The Incidence of Thromboembolism in the Surgical Intensive Care Unit." American Surgeon 69, no. 10 (2003): 857–61. http://dx.doi.org/10.1177/000313480306901008.

Full text

Abstract:

The clinical diagnosis of deep venous thrombosis (DVT) is unreliable. Studies have been performed examining the utility of frequent duplex scans. However, these studies included patients outside of the intensive care unit. The incidence of venous thromboembolism and the effect of a less intense surveillance protocol was prospectively examined at a level-1 urban trauma center for a 6 month period. During the study period there were 726 admission to the surgical intensive care unit. Sequential compression devices (SCDs) were used for DVT prophylaxis in 93 per cent of the admissions. A total of 1

APA, Harvard, Vancouver, ISO, and other styles

43

Urbankova, J., R. Quiroz, and S. Z. Goldhaber. "Intermittent pneumatic compression and deep vein thrombosis prevention in postoperative patients." Phlebology: The Journal of Venous Disease 21, no. 1_suppl (2006): 19–22. http://dx.doi.org/10.1258/026835506778243031.

Full text

Abstract:

High incidence of venous thromboembolism (VTE) makes prophylaxis, screening and treatment extremely important. Both pharmacological and mechanical techniques can be used to reduce the risk of deep vein thrombosis (DVT). Mechanical methods have been studied much less intensively than pharmacological options. The principal mechanical methods of prophylaxis are graduated compression stockings and intemittent pneumatic compression devices. We conducted a meta-analysis of all randomized controlled trials to determine the effectiveness of intermittent pneumatic compression (IPC) devices in the preve

APA, Harvard, Vancouver, ISO, and other styles

44

Azami, Milad, and Esmaiil Ghasemi Pashaklaee. "44: DETERMINATION OF FREQUENCY PERCENTAGE OF PROPHYLAXIS UTILIZATION AGAINST DEEP VEIN THROMBOSIS AMONG PATIENTS HOSPITALIZED IN DIFFERENT WARDS OF IMAM KHOMEINI TEACHING HOSPITAL." BMJ Open 7, Suppl 1 (2017): bmjopen—2016–015415.44. http://dx.doi.org/10.1136/bmjopen-2016-015415.44.

Full text

Abstract:

Background and aims:The current survey aims at determining the frequency percentage of Prophylaxis usage against deep vein thrombosis (DVT) according to ACCP instruction among the patients hospitalized in Imam Khomeini teaching hospital in Ilam.Methods:This study is descriptive and retrospective and the sampling was carried out amongst the cases of patients who were hospitalized and operated in the period occurred in March of 2012 to September of 2013 in Imam Khomeini hospital in Ilam. The type of receiving Prophylaxis was determined by ACCP (The American College of Chest Physicians) Guideline

APA, Harvard, Vancouver, ISO, and other styles

45

Austin, Luke, Charles Dante Wowkanech, Bret Cypel, et al. "Effectiveness of ASA for VTE Prophylaxis in Arthroscopic Rotator Cuff Repair." Orthopaedic Journal of Sports Medicine 6, no. 7_suppl4 (2018): 2325967118S0017. http://dx.doi.org/10.1177/2325967118s00172.

Full text

Abstract:

Objectives: Venous thromboembolic disease (VTED) is a rare complication following arthroscopic rotator cuff repair (RCR). Historical rates of symptomatic VTED after arthroscopic shoulder surgery, DVT and PE, are 0.26%, and 0.01-0.21%, respectively. At present, the American Academy of Orthopaedic Surgeons (AAOS) and American College of Chest Physicians (ACCP) have no prophylaxis guidelines specific to shoulder arthroscopy. Despite this, many surgeons prescribe Aspirin (ASA) for chemical prophylaxis following RCR. The efficacy of ASA as a thromboprophylaxis after shoulder arthroscopy is unknown,

APA, Harvard, Vancouver, ISO, and other styles

46

Money, Samuel R., and John W. York. "Development of Oral Heparin Therapy for Prophylaxis and Treatment of Deep Venous Thrombosis." Cardiovascular Surgery 9, no. 3 (2001): 211–18. http://dx.doi.org/10.1177/096721090100900302.

Full text

Abstract:

Objective: To review the current research and published literature regarding the development of oral heparin therapy for the prophylaxis and treatment of deep venous thrombosis. Background: Currently, the accepted practice of prophylaxis and/or treatment of acute deep venous thrombosis (DVT) is intravenous or subcutaneous (SQ) heparin followed by oral warfarin or SC low molecular weight heparin (LMWH) therapy followed by warfarin. Both of which are less than ideal. More recently, advances have been made towards an effective oral heparin preparation that would resolve many of the drawbacks to t

APA, Harvard, Vancouver, ISO, and other styles

47

Feliu, J., R. Lecumberri, A. Jerez, et al. "Incidence of deep venous thrombosis associated with central venous catheters (DVT-CVC) in cancer patients: A multicenter study." Journal of Clinical Oncology 24, no. 18_suppl (2006): 8627. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.8627.

Full text

Abstract:

8627 Background: The reported incidence of DVT-CVC is extremely variable (0.3–28.3% for symptomatic thrombosis and 27–66% for asymptomatic thrombosis). Data in regarding new catheter materials and insertion techniques are very limited. Likewise, the use of antithrombotic prophylaxis in cancer patients with a CVC remains debatable. Methods: A prospective epidemiologic study was performed, which included adult patients with active cancer and no history of venous thromboembolism, in whom a long term CVC was inserted. Patients were followed-up for 90 days and a bilateral upper extremity Doppler-ul

APA, Harvard, Vancouver, ISO, and other styles

48

Hunt, N., R. K. Strachan, A. N. Nicolaides, and K. T. Delis. "Incidence, Natural History and Risk Factors of Deep Vein Thrombosis in Elective Knee Arthroscopy." Thrombosis and Haemostasis 86, no. 09 (2001): 817–21. http://dx.doi.org/10.1055/s-0037-1616137.

Full text

Abstract:

Summary Aims: to determine the incidence, anatomical distribution and extent of deep vein thrombosis (DVT) in limbs undergoing elective unilateral knee arthroscopy without active prophylaxis, to evaluate its effect on venous function following early diagnosis, and to quantify the impact of risk factors on its incidence. Methods: 102 consecutive patients undergoing unilateral knee arthroscopy without prophylaxis were studied. A history was obtained with emphasis on the risk factors for thromboembolism, and physical examination and colour duplex were performed prior to and within a week after su

APA, Harvard, Vancouver, ISO, and other styles

49

Patel, Viral B., Labani M. Ghosh, and Bhalendu Vaishnav. "Deep vein thrombosis risk stratification in intensive care unit patients: a pressing need." International Journal of Research in Medical Sciences 8, no. 2 (2020): 406. http://dx.doi.org/10.18203/2320-6012.ijrms20200217.

Full text

Abstract:

Background: Risk stratification of deep vein thrombosis in patients admitted to ICU and incorporating DVT risk assessment score as a regular practice were the aim of the present study.Methods: This study was carried out in 67 patients admitted in ICU >18 years of age, over one year. Patients with confirmed DVT, <48 hours of stay, thrombocytopenia, diagnosed coagulation disorders, those who have received DVT prophylaxis in last 1 month and those with active bleeding were excluded. It was a cross sectional observational study. A SMART assessment score and pretest probability scoring card w

APA, Harvard, Vancouver, ISO, and other styles

50

Durie, Brian G. M., Paul Richardson, Antonio Palumbo, et al. "Deep Vein Thrombosis in Myeloma: Estimate of Prevelance and Recommendations for Therapy Based upon a Survey of Members of the International Myeloma Working Group (IMWG)." Blood 108, no. 11 (2006): 3571. http://dx.doi.org/10.1182/blood.v108.11.3571.3571.

Full text

Abstract:

Abstract Purpose: Deep vein thrombosis (DVT) is increasingly recognized as a major complication of thalidomide (T; Thal) and lenalidomide (R; Rev) based therapy for multiple myeloma. Estimated incidence varies widely in the literature. There is no consensus on specific risk factors, indications for thromboprophylaxis or the agent of choice for DVT prophylaxis. The purpose of this study was to develop a consensus among members of the IMWG. Patients and Methods: A survey was electronically mailed to 67 IMWG members on July 21, 2006 and consisted of 24 multiple-choice questions. Results: Twenty-t

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!